Cargando…

PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE

Detalles Bibliográficos
Autores principales: Yan, Jiali, Shahani, Shilpa, Smith, Nancy, Sun, Fang, Song, Qinghua, Xu, Hairong, Zhang, Jie, Farooq, Umar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428825/
http://dx.doi.org/10.1097/01.HS9.0000975948.06586.80
_version_ 1785090562845573120
author Yan, Jiali
Shahani, Shilpa
Smith, Nancy
Sun, Fang
Song, Qinghua
Xu, Hairong
Zhang, Jie
Farooq, Umar
author_facet Yan, Jiali
Shahani, Shilpa
Smith, Nancy
Sun, Fang
Song, Qinghua
Xu, Hairong
Zhang, Jie
Farooq, Umar
author_sort Yan, Jiali
collection PubMed
description
format Online
Article
Text
id pubmed-10428825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288252023-08-17 PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE Yan, Jiali Shahani, Shilpa Smith, Nancy Sun, Fang Song, Qinghua Xu, Hairong Zhang, Jie Farooq, Umar Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428825/ http://dx.doi.org/10.1097/01.HS9.0000975948.06586.80 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Yan, Jiali
Shahani, Shilpa
Smith, Nancy
Sun, Fang
Song, Qinghua
Xu, Hairong
Zhang, Jie
Farooq, Umar
PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title_full PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title_fullStr PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title_full_unstemmed PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title_short PB2306: REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE
title_sort pb2306: real-world first-line treatment and outcomes among patients with high-risk diffuse large b-cell lymphoma treated with standard of care
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428825/
http://dx.doi.org/10.1097/01.HS9.0000975948.06586.80
work_keys_str_mv AT yanjiali pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT shahanishilpa pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT smithnancy pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT sunfang pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT songqinghua pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT xuhairong pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT zhangjie pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare
AT farooqumar pb2306realworldfirstlinetreatmentandoutcomesamongpatientswithhighriskdiffuselargebcelllymphomatreatedwithstandardofcare